0001114220-18-000004.txt : 20180108
0001114220-18-000004.hdr.sgml : 20180108
20180108180622
ACCESSION NUMBER: 0001114220-18-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180105
FILED AS OF DATE: 20180108
DATE AS OF CHANGE: 20180108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adams Brian
CENTRAL INDEX KEY: 0001636994
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 18517459
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-466-3500
MAIL ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
wf-form4_151545276854523.xml
FORM 4
X0306
4
2018-01-05
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001636994
Adams Brian
C/O KERYX BIOPHARMACEUTICALS, INC.
ONE MARINA PARK DRIVE, 12TH FLOOR
BOSTON
MA
02210
0
1
0
0
General Counsel and Secretary
Common Stock
2018-01-05
4
S
0
753
4.69
D
133262
D
Sale of a total of 753 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 1,989 shares of restricted stock on January 4, 2018. Mr. Adams had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
Includes 71,145 shares of restricted stock.
/s/ Brian Adams
2018-01-08